Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
MicroPort NeuroTech Limited ( (HK:2172) ) has issued an announcement.
MicroPort NeuroScientific Corporation has confirmed arrangements linked to a proposed final dividend for the 2025 financial year, which remains subject to shareholder approval at the annual general meeting scheduled for 3 June 2026. The move reflects the company’s intent to return value to investors, underscoring its commitment to shareholder remuneration as it continues to develop its neurotechnology business.
To determine eligibility for the proposed final dividend, the company will close its register of members from 6 to 8 July 2026, with 8 July set as the record date. Shareholders must ensure share transfers are lodged with the Hong Kong branch registrar by 4:30 p.m. on 3 July 2026, a timetable that clarifies administrative steps for investors and signals an orderly approach to capital distribution.
More about MicroPort NeuroTech Limited
MicroPort NeuroScientific Corporation is a Cayman Islands–incorporated medical technology company listed in Hong Kong, focused on neuro-related therapies and devices through its group of subsidiaries. The company serves healthcare markets that require advanced neuro-intervention solutions, positioning itself within the broader neurotechnology and medical devices industry.
Average Trading Volume: 2,465,233
Technical Sentiment Signal: Sell
Current Market Cap: HK$6.08B
Learn more about 2172 stock on TipRanks’ Stock Analysis page.